Trials / Conditions / Nonsmall Cell Lung Cancer, Stage II
Nonsmall Cell Lung Cancer, Stage II
3 registered clinical trials studyying Nonsmall Cell Lung Cancer, Stage II — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer NCT05696782 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC NCT05873439 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Terminated | Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients NCT04398199 | Wake Forest University Health Sciences | Phase 2 |